• 1
    Dowd PRaynaud’s phenomenon. Lancet1995; 346: 283 290
  • 2
    Raynaud M De l’asphyxie locale et de la gangrene symetrique des extremities. These de Paris, Library Editor: Leclerc L, 1862
  • 3
    Miller D, Waters DD, Warnica W, Stachcic J, Kreeft J, Theroux PIs variant angina the coronary manifestation of a generalized vasospastic disorder? N Engl J Med1981; 30: 736 738
  • 4
    O’Keeffe ST, Tsapatsaris NP, Beetham WPIncreased prevalence of migraine and chest pain in patients with primary Raynaud’s disease. Ann Int Med1992; 116: 985 989
  • 5
    Zahavi I, Chagnac A, Mering R, Davidovich S, Kuritzky APrevalence of Raynaud’s phenomenon in patients with migraine. Arch Intern Med1984; 144: 742 744
  • 6
    Yanagisawa M, Kurihara H, Kimura S, et al.A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature1988; 33: 411 415
  • 7
    Furchgott RF & Zawadzki JVThe obligatory role of endothelial cells in the relaxation of arterial smooth muscle to acetylcholine. Nature1980; 228: 373 376
  • 8
    Palmer RMJ, Ferrige AG, Moncada SNitric oxide accounts for the biological activity of endothelium-derived relaxing factor. Nature1987; 327: 524 526
  • 9
    Bedarida GV, Kim D, Blaschke TF, Hoffman BBVenodilation in Raynaud’s disease. Lancet1993; 342: 1451 1454
  • 10
    Singh S, De Trafford JC, Baskerville PA, Martin JFResponse of digital arteries to endothelium dependent and independent vasodilators in patients with Raynaud’s phenomenon. Eur J Clin Invest1995; 25: 182 185
  • 11
    Khan F & Coffman JDEnhanced cholinergic cutaneous vasodilatation in Raynaud’s phenomenon. Circulation1994; 89: 1183 1188
  • 12
    Chowienczyk PJ, Cockcroft JR, Ritter JM,Differential inhibition by NG-monomethyl-l-arginine of vasodilator effects of acetylcholine and methacholine in human forearm. Br J Pharmacol1993; 110: 736 738
  • 13
    Monge L, Garcia-Villalon AL, Montoya JJ, Garcia JL, Gomez B, Dieguez GResponse of rabbit ear artery to endothelin-1 during cooling. Br J Pharmacol1991; 104: 609 612
  • 14
    Allen EV & Brown GERaynaud’s disease: a critical review of the minimal requisites for diagnosis. Am J Med1932; 183: 187 200
  • 15
    Aalkjaer C, Heagerty AM, Petersen KK, Swales JD, Mulvany MJEvidence for increased media thickness, increased neural amine uptake, and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Circ Res1987; 61: 181 186
  • 16
    Laing RJ, Jakubowski J, Morice AHAn in vitro study of the pharmacological responses of rat middle cerebral artery: effects of overnight storage. J Vasc Res1995; 32: 230 236
  • 17
    Falloon BJ, Bund SJ, Tulip JR, Heagerty AMIn vitro perfusion studies of resistance artery function in genetic hypertension. Hypertension1993; 22: 486 495
  • 18
    Vanhoutte PMPhysical factors of regulation. In Handbook of Physiology, Section 2, Circulation, Vol II, Vascular Smooth Muscle. (eds Bohr DF, Somlyo AP, Sparks HV, Bethesda, Maryland: Am Physiol Soc.), 1980: 443 474
  • 19
    Aronstam RS & Narayanan TKTemperature effect on the detection of muscarinic receptor–G protein interactions in ligand binding assays. Biochem Pharmacol1988; 37: 1045 1049
  • 20
    Vanhoutte PM & Shepherd JTEffect of temperature on reactivity of isolated cutaneous veins of the dog. Am J Physiol1970; 218: 187 190
  • 21
    Soares de Moura R & Vanhoutte PMEffect of cooling and warming on the vasodilator response of the isolated dog saphenous artery to acetylcholine. Brazilian J Med Biol Res1988; 21: 157 159
  • 22
    Moncada S, Gryglewski RJ, Bunting S, et al.An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation. Nature1976; 263: 663 667
  • 23
    Garland CJ, Plane F, Kemp BK, Cocks TMEndothelium-dependent hyperpolarization: a role in the control of vascular tone. Trends Pharmacol Sci1995; 16: 23 30
  • 24
    Deng L-Y, Li J-S, Shiffrin ELEndothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. Clin Sci1995; 88: 611 622
  • 25
    James MA, Watt PAC, Potter JF, Thurston H, Swales JDEndothelial function in subcutaneous resistance arteries from elderly hypertensive and normotensive subjects. Clin Sci1997; 92: 139 145
  • 26
    Gardner-Medwin JM, Cockcroft JR, Macdonald IA, Rowell RJReduced nitric oxide-dependent vasodilatation in primary Raynaud’s phenomenon. Br J Clin Pharmacol1996; 42: 650P–651P.
  • 27
    Khan F, Litchfield SJ, McLaren M, Veale DJ, Littleford RC, Belch JJF,Oral l-arginine supplementation and cutaneous vascular responses in patients with primary Raynaud’s phenomenon. Arth Rheum1997; 40: 352 357
  • 28
    Boulanger C & Luscher TFRelease of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest1990; 85: 587 590
  • 29
    Smith PJW, Ferro CJ, McQueen DS, Webb DJFunctional studies in small arteries do not support a primary role for endothelin in the pathogenesis of Raynaud’s disease. J Cardiovasc Pharmacol1998; 31 Suppl. 1: S473–S476